Replies to post #248115 on Biotech Values

[Whalatane]

Dew. from a quick glance ...JNJ and ABT reporting strong med tech earnings ?
Any likely read thru to SWAV's earnings early Aug ?
Interested in your opinion
thx
Kiwi

[dewophile]

The combined market cap of ABBV and ABT right now is about 450M, slightly more than JNJ.
Random trivia on a slow day between patients for me

[Biowatch]

Abbott Cuts Covid-19 Sales Guidance Again
8:22 AM ET 7/20/23 | Dow Jones

Abbott keeps slashing its guidance for sales of Covid-19 tests on the year, but is confident in growth in other parts of its business. The company says in 2Q earnings that it now expects $1.3B in Covid-19 test revenue for the full year, lower than the $1.5B it projected at the end of 1Q and the $2B forecast in January. Still, the company kept its adjusted per-share earnings guidance flat, suggesting other parts of the business will grow more than expected. Abbott shares rise 0.2% to $107.51 premarket. (ben.glickman wsj)

—————
Implies fewer people are concerned about Covid, or the government has stopped sending people free Covid test kits.

[DewDiligence]

FDA clears ABT’s 15-minute test for TBI/concussion:

https://finance.yahoo.com/news/abbott-receives-fda-clearance-whole-130000849.html

Note: This is not the hand-held diagnostic ABT is developing to give TBI results from a simple finger prick (#msg-172397644).